Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Atrial Fibrillation Management and Outcomes, and Cancer-related molecular mechanisms research.
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance
Mindfulness vs Cognitive Behavioral Therapy for Chronic Low Back Pain Treated With Opioids
Decoding disease–specific ageing mechanisms through pathway-level epigenetic clock: insights from multi-cohort validation
Ferroptosis-related proteins ALOX15 and HMOX1 are upregulated and associated with inflammation in patients with diabetic nephropathy: a prospective cross-sectional study
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma
Pre-dialysis and post-dialysis metabolic acidosis in patients receiving hemodialysis
TAK1 in Vascular Signaling: “Friend or Foe”?
Role of the histone deacetylase family in lipid metabolism: Structural specificity and functional diversity
The Activation of Endogenous Proteases in Shrimp Muscle Under Water-Free Live Transport
Risk of Bleeding, Thrombosis and Death among Atrial Fibrillation Patients Treated with Oral Anticoagulants Across Estimated Glomerular Filtration Rates
New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulants
Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China